Pharmaceutical Dissolution Testing Market Report: Regional Breakdown and Competitive Landscape
Unrivaled Expansion in Dissolution Testing for Pharmaceutical Excellence The Pharmaceutical Dissolution Testing Market is entering a new phase of accelerated innovation and global demand, poised to reach USD 52.6 billion by 2031 , from USD 25.9 billion in 2023 , at an extraordinary CAGR of 26.2% . This transformation is driven by the convergence of advanced pharmaceutical R&D, regulatory scrutiny, and the evolving landscape of drug delivery systems. Request Sample Report PDF (including TOC, Graphs & Tables): https://www.statsandresearch.com/request-sample/40458-global-pharmaceutical-dissolution-testing-market The Strategic Role of Dissolution Testing in Drug Development Dissolution testing has become indispensable to modern drug development and regulatory compliance. It quantifies the rate and extent to which the active pharmaceutical ingredient (API) is released from solid dosage forms and becomes available for absorption. The FDA , EMA , and other global regulatory bodies...